McEwen (MUX) EBITDA (2010 - 2026)

McEwen has reported EBITDA for 17 years, with the latest figure at $7.7 million in Q2 2026.

• On a quarterly basis, EBITDA rose 328.3% year-over-year to $7.7 million in Q2 2026; TTM through Jun 2026 was $62.6 million, a 344.04% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 105.25% from the prior year.
• EBITDA was $7.7 million for Q2 2026 at McEwen, down from $41.2 million in the prior quarter.
• The five-year high for EBITDA was $41.2 million in Q1 2026, with the low at -$47.4 million in Q4 2023.
• Average EBITDA over 5 years is -$14.2 million, with a median of -$15.1 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: EBITDA sank 8591.75% in 2025, then surged 639.82% in 2026.
• Over 5 years, EBITDA stood at -$39.2 million in 2022, then declined by 20.92% to -$47.4 million in 2023, then surged by 69.3% to -$14.5 million in 2024, then jumped by 251.92% to $22.1 million in 2025, then slumped by 65.13% to $7.7 million in 2026.
• The last three EBITDA figures came in at $7.7 million (Q2 2026), $41.2 million (Q1 2026), and $22.1 million (Q4 2025), per Business Quant data.